Tests electroacupuncture for weight loss in adults with obesity and prediabetes
Tests electroacupuncture against sham acupuncture and health education in adults with obesity.
Plain-language title generated from the registry record
Registry title: Effect of Electroacupuncture on Obesity
Key facts
- Where
- Shanghai, ChinaSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 65 years old?
Source: NCT05237089, who can take part
Where in China
- Shanghai Municipal Hospital of Traditional Chinese MedicineShanghai, ChinaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Shanghai Municipal Hospital of Traditional Chinese Medicine
- Trial code
- NCT05237089
- Record updated
- 10 November 2022
- Original description
The investigators describe a protocol for a randomized controlled trial to find out the effect and safety of electroacupuncture on losing weight in obese patients with prediabetes.Read full original descriptionShow less
Effects of Electroacupuncture on Weight Loss in Obese Patients With Prediabetes: a Randomized Controlled Trial
The investigators describe a protocol for a randomized controlled trial to find out the effect and safety of electroacupuncture on losing weight in obese patients with prediabetes.
Inclusion: Male or female participants aged 18-65; Participant whose BMI is ≥24.0 kg/m2; Participants whose HbA1c measurement of 5.7-6.4% both inclusive, or fasting plasma glucose measurement ≥ 6.1 mmol/liter and <7.0 mmol/liter, or 2-hour plasma glucose measurement post-challenge (oral glucose tolerance test) ≥7.8 mmol/liter and <11.1 mmol/liter; Participants with stable weight within 3 months before the start of the trial, fluctuated within 4 kg; Participants who voluntarily agree with the investigation and sign a written informed consent form for the clinical trial.
Exclusion: Patients who are taking medication which cause clinically significant weight gain or loss; Patients with secondary obesity caused by drugs or neuro-endocrine-metabolic disorders (such as hypothalamic disease and hypopituitarism); Patients who have been diagnosed with type I or type II diabetes; Patients whose Hamilton 17-item Depression Scale (HAMD-17) score >18 or have a history of other severe psychiatric disorders; Patients with severe ulcer, abscess and skin infection at the local acupuncture area; Patients with severe diseases of multiple organs, such as heart, brain, lungs, liver, kidneys, hematopoietic system or other serious diseases; Participants who have joined in other clinical trials or studies within the past 1 month; Pregnant or lactating women.